LKT Laboratories, Inc.

LKT Laboratories, Inc. is a research and development company focused on the discovery of specialty chemicals for cancer chemoprevention. We produce and distribute unique chemicals and biochemicals for all types of life science research and supply raw materials for manufacturing and repacking.

Company Website

Product Listing

Ribavirin 25 mg  | ≥98%

LKT Laboratories, Inc.

Purine nucleoside analog; DNA chain terminator.

More Information Supplier Page

×

Ribavirin

Ribavirin 50 mg  | ≥98%

LKT Laboratories, Inc.

Purine nucleoside analog; DNA chain terminator.

More Information Supplier Page

×

Ribavirin

Ribavirin 100 mg  | ≥98%

LKT Laboratories, Inc.

Purine nucleoside analog; DNA chain terminator.

More Information Supplier Page

×

Ribavirin

Ribavirin 500 mg  | ≥98%

LKT Laboratories, Inc.

Purine nucleoside analog; DNA chain terminator.

More Information Supplier Page

×

Ribavirin

Riboflavin 25 g  | ≥97%

LKT Laboratories, Inc.

Essential vitamin (B2) found in vegetables, dairy, legumes, plays a role in metabolism and oxidation-reduction reactions.

More Information Supplier Page

×

Riboflavin

Riboflavin 100 g  | ≥97%

LKT Laboratories, Inc.

Essential vitamin (B2) found in vegetables, dairy, legumes, plays a role in metabolism and oxidation-reduction reactions.

More Information Supplier Page

×

Riboflavin

Ricobendazole 50 g  | ≥98%

LKT Laboratories, Inc.

Nitroimidazole; microtubule polymerization inhibitor.

More Information Supplier Page

×

Ricobendazole

Ricobendazole 25 g  | ≥98%

LKT Laboratories, Inc.

Nitroimidazole; microtubule polymerization inhibitor.

More Information Supplier Page

×

Ricobendazole

Ricobendazole 100 g  | ≥98%

LKT Laboratories, Inc.

Nitroimidazole; microtubule polymerization inhibitor.

More Information Supplier Page

×

Ricobendazole

Ridaifen A Dihydrochloride 25 mg  | ≥98%

LKT Laboratories, Inc.

Tamoxifen derivative; potential proteasome inhibitor.

More Information Supplier Page

×

Ridaifen A Dihydrochloride

Ridaifen A Dihydrochloride 100 mg  | ≥98%

LKT Laboratories, Inc.

Tamoxifen derivative; potential proteasome inhibitor.

More Information Supplier Page

×

Ridaifen A Dihydrochloride

Ridaifen A Dihydrochloride 250 mg  | ≥98%

LKT Laboratories, Inc.

Tamoxifen derivative; potential proteasome inhibitor.

More Information Supplier Page

×

Ridaifen A Dihydrochloride

Rifampicin 1 g  | ≥98%

LKT Laboratories, Inc.

Ansamycin; bacterial DNA-dependent RNA polymerase inhibitor, RNA synthesis inhibitor.

More Information Supplier Page

×

Rifampicin

Rifampicin 5 g  | ≥98%

LKT Laboratories, Inc.

Ansamycin; bacterial DNA-dependent RNA polymerase inhibitor, RNA synthesis inhibitor.

More Information Supplier Page

×

Rifampicin

Rifampicin 25 g  | ≥98%

LKT Laboratories, Inc.

Ansamycin; bacterial DNA-dependent RNA polymerase inhibitor, RNA synthesis inhibitor.

More Information Supplier Page

×

Rifampicin

Rifamycin SV Monosodium 1 g  | ≥98%

LKT Laboratories, Inc.

Ansamycin; bacterial DNA-dependent RNA polymerase inhibitor, RNA synthesis inhibitor.

More Information Supplier Page

×

Rifamycin SV Monosodium

Rifamycin SV Monosodium 5 g  | ≥98%

LKT Laboratories, Inc.

Ansamycin; bacterial DNA-dependent RNA polymerase inhibitor, RNA synthesis inhibitor.

More Information Supplier Page

×

Rifamycin SV Monosodium

Rifaximin 500 mg  | ≥98%

LKT Laboratories, Inc.

Rifampicin derivative; DNA-dependent RNA polymerase inhibitor.

More Information Supplier Page

×

Rifaximin

Rifaximin 1 g  | ≥98%

LKT Laboratories, Inc.

Rifampicin derivative; DNA-dependent RNA polymerase inhibitor.

More Information Supplier Page

×

Rifaximin

Rifaximin 5 g  | ≥98%

LKT Laboratories, Inc.

Rifampicin derivative; DNA-dependent RNA polymerase inhibitor.

More Information Supplier Page

×

Rifaximin

Rigin 5 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, IgG derivative, tuftsin analog.

More Information Supplier Page

×

Rigin

Rigin 10 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, IgG derivative, tuftsin analog.

More Information Supplier Page

×

Rigin

Rigin 25 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, IgG derivative, tuftsin analog.

More Information Supplier Page

×

Rigin

Riluzole 25 mg  | ≥98%

LKT Laboratories, Inc.

Benzothiazole; TRPC5 agonist, PTR1 inhibitor, voltage-gated Na+ channel blocker, GLT-1 modulator.

More Information Supplier Page

×

Riluzole

Riluzole 250 mg  | ≥98%

LKT Laboratories, Inc.

Benzothiazole; TRPC5 agonist, PTR1 inhibitor, voltage-gated Na+ channel blocker, GLT-1 modulator.

More Information Supplier Page

×

Riluzole

Riluzole 500 mg  | ≥98%

LKT Laboratories, Inc.

Benzothiazole; TRPC5 agonist, PTR1 inhibitor, voltage-gated Na+ channel blocker, GLT-1 modulator.

More Information Supplier Page

×

Riluzole

Rimantadine Hydrochloride 250 mg  | ≥98%

LKT Laboratories, Inc.

Viral M2 proton channel blocker.

More Information Supplier Page

×

Rimantadine Hydrochloride

Rimantadine Hydrochloride 1 g  | ≥98%

LKT Laboratories, Inc.

Viral M2 proton channel blocker.

More Information Supplier Page

×

Rimantadine Hydrochloride

Rimantadine Hydrochloride 25 mg  | ≥98%

LKT Laboratories, Inc.

Viral M2 proton channel blocker.

More Information Supplier Page

×

Rimantadine Hydrochloride

Rimantadine Hydrochloride 50 mg  | ≥98%

LKT Laboratories, Inc.

Viral M2 proton channel blocker.

More Information Supplier Page

×

Rimantadine Hydrochloride

Risedronate Sodium Hydrate 25 mg  | ≥98%

LKT Laboratories, Inc.

Bisphosphonate; inhibits transfer of farnesyl pyrophosphate.

More Information Supplier Page

×

Risedronate Sodium Hydrate

Risedronate Sodium Hydrate 500 mg  | ≥98%

LKT Laboratories, Inc.

Bisphosphonate; inhibits transfer of farnesyl pyrophosphate.

More Information Supplier Page

×

Risedronate Sodium Hydrate

Risedronate Sodium Hydrate 100 mg  | ≥98%

LKT Laboratories, Inc.

Bisphosphonate; inhibits transfer of farnesyl pyrophosphate.

More Information Supplier Page

×

Risedronate Sodium Hydrate

Risedronic Acid 100 mg  | ≥97%

LKT Laboratories, Inc.

Bisphosphonate; inhibits transfer of farnesyl pyrophosphate.

More Information Supplier Page

×

Risedronic Acid

Risedronic Acid 25 mg  | ≥97%

LKT Laboratories, Inc.

Bisphosphonate; inhibits transfer of farnesyl pyrophosphate.

More Information Supplier Page

×

Risedronic Acid

Risedronic Acid 250 mg  | ≥97%

LKT Laboratories, Inc.

Bisphosphonate; inhibits transfer of farnesyl pyrophosphate.

More Information Supplier Page

×

Risedronic Acid

Risperidone 100 mg  | ≥98%

LKT Laboratories, Inc.

Benzisoxazole; 5-HT7 and NMDA agonist, D-amino acid oxidase inhibitor, 5-HT2A and D2 antagonist.

More Information Supplier Page

×

Risperidone

Risperidone 250 mg  | ≥98%

LKT Laboratories, Inc.

Benzisoxazole; 5-HT7 and NMDA agonist, D-amino acid oxidase inhibitor, 5-HT2A and D2 antagonist.

More Information Supplier Page

×

Risperidone

Risperidone 1 g  | ≥98%

LKT Laboratories, Inc.

Benzisoxazole; 5-HT7 and NMDA agonist, D-amino acid oxidase inhibitor, 5-HT2A and D2 antagonist.

More Information Supplier Page

×

Risperidone

RITA 50 mg  | ≥98%

LKT Laboratories, Inc.

p53 activator.

More Information Supplier Page

×

RITA

RITA 10 mg  | ≥98%

LKT Laboratories, Inc.

p53 activator.

More Information Supplier Page

×

RITA

Ritodrine Hydrochloride 250 mg  | ≥98%

LKT Laboratories, Inc.

Phenylethylamine; β2-adrenergic agonist, SK/BK and ATP-sensitive K+ channel activator.

More Information Supplier Page

×

Ritodrine Hydrochloride

Ritodrine Hydrochloride 1 g  | ≥98%

LKT Laboratories, Inc.

Phenylethylamine; β2-adrenergic agonist, SK/BK and ATP-sensitive K+ channel activator.

More Information Supplier Page

×

Ritodrine Hydrochloride

Ritodrine Hydrochloride 5 g  | ≥98%

LKT Laboratories, Inc.

Phenylethylamine; β2-adrenergic agonist, SK/BK and ATP-sensitive K+ channel activator.

More Information Supplier Page

×

Ritodrine Hydrochloride

Rivaroxaban 1 mg  | ≥98%

LKT Laboratories, Inc.

Oxazolidone derivative; Factor Xa inhibitor.

More Information Supplier Page

×

Rivaroxaban

Rivaroxaban 5 mg  | ≥98%

LKT Laboratories, Inc.

Oxazolidone derivative; Factor Xa inhibitor.

More Information Supplier Page

×

Rivaroxaban

Rivaroxaban 25 mg  | ≥98%

LKT Laboratories, Inc.

Oxazolidone derivative; Factor Xa inhibitor.

More Information Supplier Page

×

Rivaroxaban

Rivastigmine Tartrate 100 mg  | ≥98%

LKT Laboratories, Inc.

AChE and BChE inhibitor.

More Information Supplier Page

×

Rivastigmine Tartrate

Rivastigmine Tartrate 250 mg  | ≥98%

LKT Laboratories, Inc.

AChE and BChE inhibitor.

More Information Supplier Page

×

Rivastigmine Tartrate

Rivastigmine Tartrate 1 g  | ≥98%

LKT Laboratories, Inc.

AChE and BChE inhibitor.

More Information Supplier Page

×

Rivastigmine Tartrate